Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Two doses of SARS-CoV-2 vaccination induce more robust immune responses to emerging SARS-CoV-2 variants of concern than does natural infection.

Research Square(2021)10.21203/rs.3.rs-226857/v2Source: DataRank Database

Two doses of SARS-CoV-2 vaccination induce more robust immune responses to emerging SARS-CoV-2 variants of concern than does natural infection. is a research paper published in Research Square (2021). On theSindex it has a DataRank of 0.483. It has been cited 24 times.

N/A

0.483DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (23)IDs (PubMed, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.483

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (33)

Adam Harding ORCID,Javier Gilbert‐Jaramillo ORCID,Michael L. Knight ORCID,Stéphanie Longet ORCID,Anthony Brown ORCID

Live enrichment

PubMed:42529674 OpenAlex:https://openalex.org/W3150460481

National Institute for Health Research (NIHR)

Grant: NIHR200907

British Heart Foundation

Grant: RE/18/3/34214

UK Research and Innovation

Grant: MR/V027859/1

PHOSP-COVID Post-hospitalisation COVID-19 study: a national consortium to understand and improve long-term health outcomes

Wellcome Trust

Grant: 216417

Effector Functions of MAIT cells in Response to Viral Infection and Vaccines

greenLicense: cc-by

repositoryhttps://www.researchsquare.com/article/rs-226857/latest.pdf

publisherhttps://www.researchsquare.com/article/rs-226857/v2

publisherhttps://www.researchsquare.com/article/rs-226857/v2.html

repositoryhttps://doi.org/10.21203/rs.3.rs-226857/v2

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-190301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)VaccinationImmune systemVirology2019-20 coronavirus outbreakMedicineImmunologyBetacoronavirusOutbreakInfectious disease (medical specialty)DiseaseInternal medicinenavigationoperative efficiencyspine surgeryultrasonography

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Two doses of SARS-CoV-2 vaccination induce more robust immune responses to emerging SARS-CoV-2 variants of concern than does natural infection.

FAIR Checklist

DataRank Breakdown

Authors (33)

Funding (4 grants)

Open Access

Topics

Annotations (Europe PMC)